Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has granted quick monitor designation to VT3989, a novel investigational small molecule most cancers therapeutic,...
Minimally invasive and robotic surgical methods assist improve sufferers’ restoration and high quality of life, in keeping with Dr. Ravi Munver, the...
Amongst practically 300 sufferers who underwent main stomach or pelvic surgical procedures for gastrointestinal, genitourinary or gynecologic cancers, researchers discovered that distant...
The Meals and Drug Administration (FDA) has accepted Libtayo (cemiplimab-rwlc) for the adjuvant, or postsurgical, remedy of adults with cutaneous squamous cell...
